Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-28 Purchase | 2023-10-02 4:39 pm | Transcode Therapeutics Inc. | RNAZ | Fitzgerald Thomas A Chief Financial Officer | 49,350 | $0.51 | $25,169 | 56,318 (Direct) | View |
| 2022-06-16 Purchase | 2022-06-17 4:01 pm | Transcode Therapeutics Inc. | RNAZ | Fitzgerald Thomas A Chief Financial Officer | 12,000 | $1.27 | $15,240 | 139,377 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-14 Option Award | 2024-06-18 4:15 pm | N/A 2034-06-13 | Transcode Therapeutics Inc. | RNAZ | Fitzgerald Thomas A Interim CEO, CFO | 650,000 | $0 | 650,000 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-19 8:07 pm | N/A 2033-05-18 | Transcode Therapeutics Inc. | RNAZ | Fitzgerald Thomas A Chief Financial Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-12-12 Option Award | 2022-12-14 8:13 pm | N/A 2032-12-11 | Transcode Therapeutics Inc. | RNAZ | Fitzgerald Thomas A Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:12 pm | N/A 2032-02-29 | Transcode Therapeutics Inc. | RNAZ | Fitzgerald Thomas A Chief Financial Officer | 52,000 | $0 | 52,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 06:04 am | N/A 2031-01-31 | Transcode Therapeutics Inc. | RNAZ | Fitzgerald Thomas A Chief Financial Officer | 33,000 | $0 | 33,000 (Direct) | View |
Ownership | 2021-07-08 9:53 pm | N/A N/A | Transcode Therapeutics Inc. | RNAZ | Fitzgerald Thomas A VP, Chief Financial Officer | 0 | $0 | 369,999 (Direct) | View |